Todos Med Ltd (TOMDF)

[theswordman]

I agree 100%. And even linked for the CEO (from Stanford) the Stanford long covid trial but he seems content?? with the Amerimmune panel and that direction. I wish they would try and participate in ANY PASC (or covid)trial that is govt sponsored or has funding. I understand there has to be selection where/when it is not sponsored and gets expensive quickly

There is only 1 approved drug (FDA) for the S2C group that has any positive effect. Big Pharm seems content with vaxx approach--as do most of US population accept +1000 covid deaths per week--and we saw where worldwide it is 1 death every 4 mins.

But as more and more succumb to long haulers--more Drs will see and use Tollovid for viral eradication. The Paxlovid full approval is a plus for TolloVID--not a negative as the FUDsters have tried to spin. 3CL Protease Inhibitors work. The more that get approved the better